株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

自己免疫疾患診断の世界市場:2020年~2024年

Global Autoimmune Disease Diagnostics Market 2020-2024

発行 TechNavio (Infiniti Research Ltd.) 商品コード 373473
出版日 ページ情報 英文 120 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.54円で換算しております。
自己免疫疾患診断の世界市場:2020年~2024年 Global Autoimmune Disease Diagnostics Market 2020-2024
出版日: 2020年03月22日 ページ情報: 英文 120 Pages
概要

世界の自己免疫疾患診断市場は、2020年から2024年の予測期間中に9%のCAGRで成長し、19億4,000万米ドルの規模に達する見込みです。 市場は、自己免疫診断の改善につながる新規バイオマーカーの発見が主な成長要因となっています。また、消費者直販型検査へのシフトの拡大によって、更に市場成長が促進される見通しです。

当レポートでは、世界の自己免疫疾患診断市場について調査分析し、市場規模および成長率、市場動向、市場促進要因、課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

エグゼクティブサマリー

市場情勢

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 2019年の市場規模
  • 市場の見通し:2019年から2024年の予測

ファイブフォース分析

製品別市場セグメンテーション

  • 市場区分
  • 製品別比較:市場規模と予測2019-2024
  • アッセイキット
  • アナライザー
  • 製品別の市場機会

タイプ別市場セグメンテーション

  • 市場区分
  • タイプ別比較:市場規模と予測2019-2024
  • 限局性自己免疫疾患診断
  • 全身性自己免疫疾患診断
  • タイプ別の市場機会

顧客情勢

  • 概要

地域別情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模と予測2019-2024
  • 北米
  • 欧州
  • アジア太平洋地域
  • 南米
  • 中東・アフリカ地域
  • 主要国
  • 地域の市場機会

成長要因、課題、および動向

  • 市場成長要因
  • 数量的成長要因-需要主導型成長
  • 数量的成長要因-供給主導型成長
  • 数量的成長要因-外部要因
  • 数量的成長要因-隣接市場での需要シフト
  • 価格上昇要因-インフレ
  • 価格上昇要因-低価格ユニットから高価格ユニットへの移行
  • 市場の課題
  • 市場動向

ベンダー情勢

  • 概要
  • 情勢の革新

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Hemagen Diagnostics, Inc.
  • HOB Biotech Group Corp.
  • Quest Diagnostics Inc.
  • Siemens AG
  • Thermo Fisher Scientific Inc.

付録

目次
Product Code: IRTNTR41431

Technavio has been monitoring the global autoimmune disease diagnostics market and it is poised to grow by USD 1.94 bn during 2020-2024, progressing at a CAGR of 9% during the forecast period. Our reports on global autoimmune disease diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by discovery of novel biomarkers leading to improved autoimmune diagnosis. In addition, growing consumer shift toward direct-to-consumer testing is anticipated to boost the growth of the global autoimmune disease diagnostics market as well.

Market Segmentation

Technavio's ‘ global autoimmune disease diagnostics market ’ is segmented as below:

Product:

  • Assay Kits
  • Analyzers

Type:

  • Localized Autoimmune Disease Diagnostics
  • Systemic Autoimmune Disease Diagnostics

End-User:

  • Hospitals and Diagnostic
  • Research Laboratories

Test:

  • ANA Tests
  • CRP
  • Urinalysis Test
  • ESR
  • AMP Test
  • Other Tests

Geographic segmentation

  • North America
  • APAC
  • Europe
  • South America
  • MEA

Key Trends for global autoimmune disease diagnostics market growth

This study identifies growing consumer shift toward direct-to-consumer testing as the prime reasons driving the global autoimmune disease diagnostics market growth during the next few years.

Prominent vendors in global autoimmune disease diagnostics market

We provide a detailed analysis of around 25 vendors operating in the global autoimmune disease diagnostics market 2020-2024, including some of the vendors such as Abbott Laboratories, bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Hemagen Diagnostics Inc., HOB Biotech Group Corp., Quest Diagnostics Inc., Siemens AG and Thermo Fisher Scientific Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Assay kits - Market size and forecast 2019-2024
  • Analyzers - Market size and forecast 2019-2024
  • Market opportunity by Product

Market Segmentation by Type

  • Market segments
  • Comparison by Type
  • Localized autoimmune disease diagnostics - Market size and forecast 2019-2024
  • Systemic autoimmune disease diagnostics - Market size and forecast 2019-2024
  • Market opportunity by Type

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Hemagen Diagnostics, Inc.
  • HOB Biotech Group Corp.
  • Quest Diagnostics Inc.
  • Siemens AG
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 5
  • 5.Key Finding 6
  • 6.Key Finding 7
  • 7.Key Finding 8
  • 8.Key Finding 9
  • 9.Market in focus
  • 11.Parent market
  • 14.Market characteristics
  • 16.Offerings of vendors included in the market definition
  • 18.Market segments
  • 23.Global - Market size and forecast 2019 - 2024 ($ million)
  • 24.Global market: Year-over-year growth 2019 - 2024 (%)
  • 25.Five forces analysis 2019 & 2024
  • 28.Bargaining power of buyers
  • 30.Bargaining power of suppliers
  • 31.Threat of new entrants
  • 32.Threat of substitutes
  • 33.Threat of rivalry
  • 35.Market condition - Five forces 2019
  • 37.Product placement - Market share 2019-2024 (%)
  • 38.Comparison by Product
  • 41.Assay kits - Market size and forecast 2019-2024 ($ million)
  • 42.Assay kits - Year-over-year growth 2019-2024 (%)
  • 45.Analyzers - Market size and forecast 2019-2024 ($ million)
  • 46.Analyzers - Year-over-year growth 2019-2024 (%)
  • 48. Market opportunity by Product
  • 50.Type placement - Market share 2019-2024 (%)
  • 51.Comparison by Type
  • 54.Localized autoimmune disease diagnostics - Market size and forecast 2019-2024 ($ million)
  • 55.Localized autoimmune disease diagnostics - Year-over-year growth 2019-2024 (%)
  • 58.Systemic autoimmune disease diagnostics - Market size and forecast 2019-2024 ($ million)
  • 59.Systemic autoimmune disease diagnostics - Year-over-year growth 2019-2024 (%)
  • 61. Market opportunity by Type
  • 62.Customer landscape
  • 64.Market share by geography 2019-2024 (%)
  • 65.Geographic comparison
  • 68.North America - Market size and forecast 2019-2024 ($ million)
  • 70.North America - Year-over-year growth 2019-2024 (%)
  • 73.Europe - Market size and forecast 2019-2024 ($ million)
  • 75.Europe - Year-over-year growth 2019-2024 (%)
  • 78.APAC - Market size and forecast 2019-2024 ($ million)
  • 80.APAC - Year-over-year growth 2019-2024 (%)
  • 83.South America - Market size and forecast 2019-2024 ($ million)
  • 85.South America - Year-over-year growth 2019-2024 (%)
  • 88.MEA - Market size and forecast 2019-2024 ($ million)
  • 90.MEA - Year-over-year growth 2019-2024 (%)
  • 92.Key leading countries
  • 94.Market opportunity by geography ($ million)
  • 95.Impact of drivers and challenges
  • 96.Vendor landscape
  • 98.Landscape disruption
  • 100.Industry risks
  • 103.Vendors covered
  • 105.Market positioning of vendors
  • 107.Abbott Laboratories - Overview
  • 108.Abbott Laboratories - Business segments
  • 109.Abbott Laboratories - Key offerings
  • 110.Abbott Laboratories - Key customers
  • 111.Abbott Laboratories - Segment focus
  • 113. bioMerieux SA - Overview
  • 114. bioMerieux SA - Business segments
  • 115. bioMerieux SA - Key offerings
  • 116. bioMerieux SA - Key customers
  • 117. bioMerieux SA - Segment focus
  • 119.Bio-Rad Laboratories Inc. - Overview
  • 120.Bio-Rad Laboratories Inc. - Business segments
  • 121.Bio-Rad Laboratories Inc. - Key offerings
  • 122.Bio-Rad Laboratories Inc. - Key customers
  • 123.Bio-Rad Laboratories Inc. - Segment focus
  • 125.Danaher Corp. - Overview
  • 126.Danaher Corp. - Business segments
  • 127.Danaher Corp. - Key offerings
  • 128.Danaher Corp. - Key customers
  • 129.Danaher Corp. - Segment focus
  • 131.F. Hoffmann-La Roche Ltd. - Overview
  • 132.F. Hoffmann-La Roche Ltd. - Business segments
  • 133.F. Hoffmann-La Roche Ltd. - Key offerings
  • 134.F. Hoffmann-La Roche Ltd. - Key customers
  • 135.F. Hoffmann-La Roche Ltd. - Segment focus
  • 137.Hemagen Diagnostics Inc. - Overview
  • 138.Hemagen Diagnostics Inc. - Product and service
  • 139.Hemagen Diagnostics Inc. - Key offerings
  • 140.Hemagen Diagnostics Inc. - Key customers
  • 141.Hemagen Diagnostics Inc. - Segment focus
  • 143.HOB Biotech Group Corp. - Overview
  • 144.HOB Biotech Group Corp. - Product and service
  • 145.HOB Biotech Group Corp. - Key offerings
  • 146.HOB Biotech Group Corp. - Key customers
  • 147.HOB Biotech Group Corp. - Segment focus
  • 149.Quest Diagnostics Inc. - Overview
  • 150.Quest Diagnostics Inc. - Business segments
  • 151.Quest Diagnostics Inc. - Key offerings
  • 152.Quest Diagnostics Inc. - Key customers
  • 153.Quest Diagnostics Inc. - Segment focus
  • 155.Siemens AG - Overview
  • 156.Siemens AG - Business segments
  • 157.Siemens AG - Key offerings
  • 158.Siemens AG - Key customers
  • 159.Siemens AG - Segment focus
  • 161.Thermo Fisher Scientific Inc. - Overview
  • 162.Thermo Fisher Scientific Inc. - Business segments
  • 163.Thermo Fisher Scientific Inc. - Key offerings
  • 164.Thermo Fisher Scientific Inc. - Key customers
  • 165.Thermo Fisher Scientific Inc. - Segment focus
  • 167.Currency conversion rates for US$
  • 168.Research Methodology
  • 169.Validation techniques employed for market sizing
  • 170.Information sources
  • 171. List of abbreviations